ALLERGY IMMUNOTHERAPY MARKET SIZE & SHARE ANALYSIS - GROWTH TRENDS & FORECASTS (2023 - 2028)
Allergy Immunotherapy Market Analysis:
The Global Allergy Immunotherapy Market is projected to experience significant growth, with an anticipated increase in value from USD 2.2 billion in 2023 to USD 3.04 billion by 2028. This growth is expected to occur at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023–2028.
The COVID-19 pandemic had a detrimental impact on communities, industries, businesses, and individuals worldwide. While many companies focused their research and development efforts on creating vaccines against the SARS-CoV-2 virus, it remained crucial to provide continuous treatment and medication supply to allergy patients. Healthcare professionals continued to administer treatments or offer treatment advice during the pandemic to ensure the well-being of these patients.
For example, a study published in February 2021 by Allergy, Asthma & Immunology Research recommended that allergic patients suffering from asthma, rhinitis, atopic dermatitis, or chronic urticaria should receive maintenance therapy in a well-controlled manner during the pandemic. Similarly, a study published in February 2021 by Current Allergy and Asthma Reports highlighted the implementation of remote healthcare tools for first visits or monitored patients to continue the treatment of allergic rhinitis during the pandemic. It also suggested continuing treatment for uninfected patients or those who had recovered from COVID-19 infection, while interrupting treatment for individuals with positive or suspected SARS-CoV-2 infection.
These instances indicate that the allergy immunotherapy market is expected to continue growing even after the pandemic, as the need for continuous treatment and medication supply for allergy patients remains essential.
Get the free sample report of the Allergy Immunotherapy Market
Comments
Post a Comment